Bicarbonate Solution 0.89 mEq Solution is a Health Canada–registered veterinary drug (DIN 02455137) held by Alberta Veterinary Laboratories Ltd, containing Sodium Bicarbonate. Health Canada lists its status as Approved (status date 25 May 2016). Nexara Health has matched 260 registrations of Sodium Bicarbonate across 17 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02455137 |
|---|---|
| Brand name | Bicarbonate Solution |
| Active ingredient | Sodium Bicarbonate |
| Strength | 0.89 mEq |
| Dosage form | Solution |
| Route | Intravenous |
| Company | Alberta Veterinary Laboratories Ltd |
| Status | Approved — 25 May 2016 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Sodium Bicarbonate registered in other markets
260 registrations of the same molecule in 17 national registries outside Canada (first 76 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Saudi Arabia | Sodium Bicarb. Solution Cat.no 3f-005 | — | 8.4 | Inactive | SFDA | |
| Australia | Sodium Bicarbonate | — | EP | PBS | ||
| Australia | Sodium Bicarbonate | — | EP | PBS | ||
| Bahrain | 8.4% Sodium Bicarbonate Iv Infusion BP | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 8.4 % W/V | Solution For Infusion | POM | NHRA |
| Bahrain | 8.4% W/V Sodium Bicarbonate | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 8.4 %W/V | Solution For Infusion | POM | NHRA |
| Czech Republic | Ardeaelytosol Conc. Natriumhydrogenkarbon�T 4,2% | — | 42MG/ML | Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Ardeaelytosol Conc. Natriumhydrogenkarbon�T 8,4% | — | 84MG/ML | Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Hydrogenuhli�Itan Sodn� B. Braun 4,2% | — | 42MG/ML | Inf Sol | R | SUKL DLP |
| Czech Republic | Hydrogenuhli�Itan Sodn� B. Braun 8,4% | — | 84MG/ML | Inf Sol | R | SUKL DLP |
| Greece | ΝΑΤΡΙΟ ΑΝΘΡΑΚΙΚΟ ΟΞΙΝΟ/DEMO INJ.SOL 4% BTx 50AMPS γυάλινες x10ML | Demo Abee | reimbursed | MoH deltio timwn | ||
| Greece | Νατριο Ανθρακικο Οξινο/Demo Inj.sol 4% Btx1ampx10ml | Demo Abee | reimbursed | MoH deltio timwn | ||
| Hong Kong | Advance Gripe Mixture 0.3% | Advance Pharmaceutical Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Andrex Baby Water | Advance Pharmaceutical Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Antacimin Tab 300mg | Synco (H.k.) Limited | Registered | DH Drug Office | ||
| Hong Kong | Gelsive Sodium Bicarbonate Tablets 300mg | Welldone Pharmaceuticals Limited | Registered | DH Drug Office | ||
| Hong Kong | Hap Gripe Mixture 0.3% | Advance Pharmaceutical Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Harex Gripe Mixture | Advance Pharmaceutical Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Prolyter Baby Water 0.3% | Advance Pharmaceutical Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Sod Bicarbonate Inj 8.4% | B. Braun Medical (Hk) Ltd | Registered | DH Drug Office | ||
| Ireland | 8.4% w/v Sodium Bicarbonate Intravenous Infusion BP | B. Braun Medical Limited | Solution for infusion | Marketed | HPRA | |
| Lebanon | Sodium Bicarbonate | Alfa Laboratoires S.A.L. | 1.4g/100ml | Injectable solution | MoPH | |
| Lebanon | Sodium Bicarbonate | Alfa Laboratoires S.A.L. | 4.2g/100ml | Injectable solution | MoPH | |
| Lebanon | Sodium Bicarbonate | Alfa Laboratoires S.A.L. | 8.4% | Injectable solution | MoPH | |
| Malaysia | B. Braun 8.4% Sodium Bicarbonate Iv Infusion BP (100ml) | B. Braun Medical Industries Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | DB Sodium Bicarbonate 8.4% w/v Injection | Duopharma (M) Sendirian Berhad | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Pharmaniaga Sodium Bicarbonate 8.4% w/v Injection | Pharmaniaga Lifescience Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malta | SODIUM BICARBONATE MONICO 8.4% - solution for infusion | Monico spa | Solution For Infusion | Authorised | Medicines Authority | |
| Malta | Sodium bicarbonate NOVA ARGENTIA 500 mg tablets | Central Procurement & Supplies Unit | Tablet | Authorised | Medicines Authority | |
| Saudi Arabia | Basic Bicarbonate Concentrate 8.125% Inf | — | 8.125 | Inactive | SFDA | |
| Saudi Arabia | Basic Bicarbonate Concentrate 8.4% Infus | — | 8.4 | Inactive | SFDA | |
| Saudi Arabia | Hemodialysis Grade Sod.bicarb(3p001)840g | — | 840 | Inactive | SFDA | |
| Saudi Arabia | Hemodialysis Grade Sod.bicarb(3p003)650g | — | 650 | Inactive | SFDA | |
| Saudi Arabia | Seretide Evohaler | — | 250,25 | Active | SFDA | |
| Saudi Arabia | Sod.bicarbonate 4.2% Inj | — | 4.2 | Inactive | SFDA | |
| Saudi Arabia | Sodium Bicarbonate 5% Infusion | — | 5 | Inactive | SFDA | |
| Singapore | Bibag (5008 Design) Powder For Haemodialysis | Fresenius Medical Care Singapore Pte. Ltd. | 100% | Powder, For Solution | General Sale List | HSA |
| Singapore | Bibag Powder For Haemodialysis | Fresenius Medical Care Singapore Pte. Ltd. | 100% | Powder, For Solution | General Sale List | HSA |
| Singapore | Bicart Powder For Haemodialysis | Vantive Pte. Ltd. | 100% | Powder, For Solution | General Sale List | HSA |
| Singapore | SODIUM BICARBONATE CAPSULE 500 mg | Beacons Pharmaceuticals Pte. Ltd. | 500 mg | Capsule | Prescription Only | HSA |
| Singapore | Sodium Bicarbonate Injection BP 8.4% | B. Braun Singapore Pte Ltd | 8.4 g/100 ml | Injection | General Sale List | HSA |
| Singapore | SODIUM BICARBONATE INTRAVENOUS INFUSION 8.4% w/v | B. Braun Singapore Pte Ltd | 8.4% w/v | Injection | General Sale List | HSA |
| Singapore | SODIUM BICARBONATE INTRAVENOUS INFUSION BP 4.2% w/v | B. Braun Singapore Pte Ltd | 4.2% w/v | Injection | General Sale List | HSA |
| South Africa | Alkaline Bicarbonate Haemodialysis Concemtrate 8.4% Solution | B. Braun Medical (Pty) Ltd | 84 g/1000ml | Dia | Discountinued | DoH SEP database |
| South Africa | Alkaline Bicarbonate Haemodialysis Concentrate 8.4% Solution | B. Braun Medical (Pty) Ltd | 84 g/L | Sol | Discountinued | DoH SEP database |
| South Africa | Alkaline Bicarbonate Haemodialysis Concentrate 8.4% Solution | B. Braun Medical (Pty) Ltd | 84 g/L | Sol | Discountinued | DoH SEP database |
| South Africa | Alkaline Bicarbonate Haemodialysis Concentrate 8.4% Solution | B. Braun Medical (Pty) Ltd | 84 g/L | Sol | Discountinued | DoH SEP database |
| South Africa | Intramed Sodium Bicarbonate Injection 8.5% M/V | Bodene (Pty) Ltd | g/50 ml | Inj | S3 | DoH SEP database |
| South Africa | Intramed Sodium Bicarbonate Injection 8.5% M/V | Bodene (Pty) Ltd | g/50 ml | Inj | S3 | DoH SEP database |
| South Africa | Sabax Liq Bicarb Concentrate 8.4% | Adcock Ingram Critical Care (Pty) Ltd | 84 g | Sol | S3 | DoH SEP database |
| South Africa | Sabax Sod Bicarb 4.2% 200Ml | Adcock Ingram Critical Care (Pty) Ltd | g/1000ml | Inf | S3 | DoH SEP database |
| Taiwan | Sodium Bicarbonate | Xinxing Lingyun Phar Maceutical And Chemical Co., Ltd. | 原料藥粉末 | 已註銷 | TFDA | |
| Taiwan | Sodium Bicarbonate | Solvay Peroxythai Limited | (粉) | Registered | TFDA | |
| Taiwan | Sodium Bicarbonate | Novabay Pte. Ltd. | (粉) | Registered | TFDA | |
| Turkey | Molar Sodyum Bikar. 10 mL 10 Ampul | Osel İlaç San. Ve Ti̇c. A.ş. | Aktif | TITCK | ||
| Turkey | Sodyum Bic.mol.%8.4 10 mL 10 Ampul | Galen İlaç San.ve Ti̇c.a.ş | Aktif | TITCK | ||
| Turkey | Sodyum Bikar. %8,4 Infuzyon Icin Cozelti Iceren 10 Ampul | Onfarma İlaç Sanayi̇ Ltd.şti̇. | Aktif | TITCK | ||
| Turkey | Turktipsan Molar Sodyum 840 mg/10 mL Iv Enjeksiyonluk Cozelti (10 Ampul) | Turktipsan Sağlik Turi̇zm Eği̇ti̇m Ve Ti̇caret A.ş. | Aktif | TITCK | ||
| United Arab Emirates | 8.4% Sodium Bicarbonate w/v B.P. [PSI] | PHARMACEUTICAL SOLUTION INDUSTRY LTD. (PSI), Saudi Arabia, Jeddah | 8.4%W/V | Infusion | Active | EDE |
| United Arab Emirates | 8.4% Sodium Bicarbonate w/v B.P. [PSI] | PHARMACEUTICAL SOLUTION INDUSTRY LTD. (PSI), Saudi Arabia, Jeddah | 8.4%W/V | Infusion | Active | EDE |
| United Arab Emirates | SODIUM BICARBONATE VIAFLO 1.4 % [Baxter] | Bieffe Medital S.A, Spain, Sabiñanigo | 1.4 % | Infusion | Active | EDE |
| United Kingdom | Sodium bicarbonate 0.625% mouthwash | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Sodium bicarbonate 1.26% infusion 500ml polyethylene bottles | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Sodium bicarbonate 1.26g / Simeticone 42microgram granules 2.8g sachets sugar free | — | 0002 | NHS dm+d VMP | ||
| United Kingdom | Sodium bicarbonate 1.4% infusion 500ml polyethylene bottles | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Sodium bicarbonate 1.5% / Sodium chloride 1.5% irrigation solution 250ml bottles | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Sodium bicarbonate 1% topical solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Sodium bicarbonate 100mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Sodium bicarbonate 10mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United States | ADRIAN BICARBONATO SODIUM BICARBONATE USP-4 oz, 8 oz and 16 oz | Evi Labs | Powder | listed | FDA NDC | |
| United States | After Bite Advanced | Tender Corporation d/b/a Adventure Ready Brands | Liquid | listed | FDA NDC | |
| United States | After Bite Kids | Tender Corporation d/b/a Adventure Ready Brands | Cream | listed | FDA NDC | |
| United States | After Bite X Tech | Adventure Ready Brands | Liquid | listed | FDA NDC | |
| United States | AHHH Bite Relief | 78271 | Gel | listed | FDA NDC | |
| United States | Anti-Empacho | Menper Distributors, Inc. | Liquid | listed | FDA NDC | |
| United States | Arm and Hammer Baking Soda | Church & Dwight Co., Inc. | Powder | listed | FDA NDC | |
| United States | Bestmade Natural Products Sodium Bicarbonate (Nat Bicarb) | Bestmade Natural Products | Tablet, Soluble | listed | FDA NDC |
See every manufacturer of Sodium Bicarbonate worldwide →
Regulator price references for Sodium Bicarbonate
Published list or reimbursement prices for Sodium Bicarbonate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Saudi Arabia | Sodium Bicarb. Solution Cat.no 3f-005 | 19.30 SAR | public | SFDA | 2026-09-01 | ||
| Bahrain | 8.4% W/V Sodium Bicarbonate | 8.4pct | 50ML | 0.71 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | 8.4% Sodium Bicarbonate Iv Infusion BP | 8.4pct | 250ML | 2.80 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | Νατριο Ανθρακικο Οξινο/Demo Inj.sol 4% Btx1ampx10ml | 10ml+4pct | 0.16 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ΝΑΤΡΙΟ ΑΝΘΡΑΚΙΚΟ ΟΞΙΝΟ/DEMO INJ.SOL 4% BTx 50AMPS γυάλινες x10ML | 10ml+4pct | 0.16 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Lebanon | Sodium Bicarbonate | 1400mg/100ml | 500ml | 2.89 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Lebanon | Sodium Bicarbonate | 4200mg/100ml | 10 x 20ml | 8.29 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Lebanon | Sodium Bicarbonate | 8.4pct | 10 x 20ml | 10.72 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Saudi Arabia | Sodium Bicarbonate 8.4% Inj. | 8.4pct | 7.85 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Sodium Bicarbonate 8.4% Inj | 8.4pct | 8.85 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Sodium Bicarbonate 840gm Powder | 9.80 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Hemodialysis Grade Sod.bicarb(3p003)650g | 650000mg | 10.15 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Hemodialysis Grade Sod.bicarb(3p001)840g | 840000mg | 13.10 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Sodium Bicarbonate 5% Infusion | 5pct | 13.80 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Sod.bicarbonate 4.2% Inj | 4.2pct | 20.15 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Sodium Bicarbonate 8.4% Inj | 8.4pct | 21.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Zymar 0.3% Ophthalmic Solution | 5pct | 28.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Sodium Bicarbonate 8.4% Inj | 8.4pct | 30.95 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Basic Bicarbonate Concentrate 8.125% Inf | 8.125pct | 35.50 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Basic Bicarbonate Concentrate 8.4% Infus | 8.4pct | 37.95 SAR | public | SFDA | 2026-09-01 | |
| South Africa | Sodium Bicarbonate 4% Injection Fresenius | 2000mg/50ml | 50 | 71.64 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Solcart B 605g Heamodialysis | 650000mg | 650 | 72.33 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Intramed Sodium Bicarbonate Injection 8.5% M/V | 50ml | 50 | 90.94 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Alkaline Bicarbonate Haemodialysis Concentrate 8.4% Solution | 84000mg/1000ml | 6 | 112.58 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Alkaline Bicarbonate Haemodialysis Concemtrate 8.4% Solution | 84000mg/1000ml | 10 | 114.41 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Alkaline Bicarbonate Haemodialysis Concentrate 8.4% Solution | 84000mg/1000ml | 10 | 175.73 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Sabax Sod Bicarb 4.2% 200Ml | 1000ml | 200 | 214.02 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Alkaline Bicarbonate Haemodialysis Concentrate 8.4% Solution | 84000mg/1000ml | 6 | 225.13 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Sabax Liq Bicarb Concentrate 8.4% | 84000mg | 5000 | 279.36 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Sodium Bicarbonate 4% Injection Fresenius | 2000mg/50ml | 50 | 716.47 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Intramed Sodium Bicarbonate Injection 8.5% M/V | 50ml | 50 | 909.42 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Sabax Sod Bicarb 4.2% 200Ml | 42000mg/1000ml | 200 | 2,569.44 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| United Arab Emirates | 8.4% Sodium Bicarbonate w/v B.P. [PSI] | 8.4pct | 50ml Vial | 5.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | 8.4% Sodium Bicarbonate w/v B.P. [PSI] | 8.4pct | 250 ml Glass bottle | 10.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | SODIUM BICARBONATE VIAFLO 1.4 % [Baxter] | 1.4pct | 20 Viaflo Bags (500 mL) | 133.50 AED | public | EDE | 2026-08-31 |
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 02516225 | Sodium Bicarbonate Injection USP | Jamp Pharma Corporation | 84 mg | Solution |
| 02467585 | Sodium Bicarbonate Injection USP | Omega Laboratories Limited | 84 mg | Solution |
| 00261998 | Sodium Bicarbonate Injection USP | Pfizer Canada ULC | 84 mg | Solution |
| 02541904 | Sodium Bicarbonate Injection USP | Sterimax Inc | 84 mg | Solution |
| 02486636 | Sodium Bicarbonate Injection, USP | Fresenius Kabi Canada Ltd | 84 mg | Solution |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Bicarbonate Solution (DIN 02455137) marketed in Canada?
No. Health Canada lists DIN 02455137 as Approved as of 25 May 2016.
Who holds the Canadian licence for this product?
Alberta Veterinary Laboratories Ltd is the company of record in the Health Canada Drug Product Database.
Is Sodium Bicarbonate registered outside Canada?
Yes — Nexara Health has matched 260 registrations in 17 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02455137, status date 2016-05-25; national medicine registries: DH Drug Office, DoH SEP database, EDE, FDA NDC, HPRA, HSA, Medicines Authority, MoH deltio timwn, MoPH, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK; price sources: DoH SEP database, EDE, MoH deltio timwn, MoPH, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02455137, status date 2016-05-25; national medicine registries: DH Drug Office, DoH SEP database, EDE, FDA NDC, HPRA, HSA, Medicines Authority, MoH deltio timwn, MoPH, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK; price sources: DoH SEP database, EDE, MoH deltio timwn, MoPH, NHRA, SFDA.
Health Canada Drug Product Database (DPD), DIN 02455137, status date 2016-05-25; national medicine registries: DH Drug Office, DoH SEP database, EDE, FDA NDC, HPRA, HSA, Medicines Authority, MoH deltio timwn, MoPH, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK; price sources: DoH SEP database, EDE, MoH deltio timwn, MoPH, NHRA, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.